Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...
Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...
Hosted on MSN22d
Attentive.ai completes $12M Series A round to expand AI offerings for the construction industryNew Delhi [India], January 24: Attentive.ai, a leading AI-based SaaS startup, today announced the successful close of its Series A2 funding round, completing a $12M raise in Series A in two ...
AI judging. Sports betting. Fantasy sports. And soon, a year-round, team-based league format. It’s a brave new world for X Games, and under majority owner MSP Sports Capital and new CEO Jeremy ...
Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...
Piper Sandler analyst Christopher Raymond maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price ...
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
Gemini 2.0 Flash is the base model that powers the free version of Gemini. It replaces Gemini 1.5 Flash which was released ...
Bruker Corporation announced the launch of the VERTEX NEO Platform with its first product, the VERTEX NEO R. This release marks a continuation of providing high-end Fourier-Transform Infrared (FTIR) ...
The stock's fall snapped a four-day winning streak.
Google released Gemini 2.0 Flash for Google AI Studio and Vertex AI. The “Flash” in this ... It replaces Gemini 1.5 Flash which was released last year. That model came about halfway through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results